Tcw Group Inc Pfizer Inc Transaction History

Tcw Group Inc

$11.2 Billion
Q3 2024

A detailed history of Tcw Group Inc transactions in Pfizer Inc stock. As of the latest transaction made, Tcw Group Inc holds 77,567 shares of PFE stock, worth $2.04 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

77,567

Previous 77,567 -0.0%

Holding current value

$2.04 Million

Previous $2.24 Million -0.0%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$27.7 - $31.39 $50,663 - $57,412	-1,829 Reduced 2.3%	77,567 $2.24 Million
Q2 2024 Jul 18, 2024	BUY	$25.26 - $29.6 $83,762 - $98,153	3,316 Added 4.36%	79,396 $2.22 Million
Q1 2024 May 09, 2024	SELL	$25.89 - $29.73 $3.35 Million - $3.84 Million	-129,296 Reduced 62.96%	76,080 $2.11 Million
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $2.43 Million - $3.16 Million	92,970 Added 82.71%	205,376 $5.91 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $199,214 - $232,862	-6,208 Reduced 5.23%	112,406 $3.73 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $152,209 - $176,103	4,214 Added 3.68%	118,614 $4.35 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $2.34 Million - $3.05 Million	59,517 Added 108.44%	114,400 $4.67 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $9,894 - $12,916	-237 Reduced 0.43%	54,883 $2.81 Million
Q3 2022 Oct 27, 2022	SELL	$43.76 - $53.42 $620,954 - $758,029	-14,190 Reduced 20.47%	55,120 $2.41 Million
Q2 2022 Jul 19, 2022	BUY	$46.53 - $55.17 $125,026 - $148,241	2,687 Added 4.03%	69,310 $3.63 Million
Q1 2022 Apr 19, 2022	SELL	$45.75 - $56.69 $616,023 - $763,330	-13,465 Reduced 16.81%	66,623 $3.45 Million
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $142,182 - $210,761	-3,441 Reduced 4.12%	80,088 $4.73 Million
Q3 2021 Oct 26, 2021	BUY	$39.25 - $50.42 $41,840 - $53,747	1,066 Added 1.29%	83,529 $3.59 Million
Q2 2021 Jul 23, 2021	SELL	$35.91 - $40.68 $2.18 Million - $2.47 Million	-60,664 Reduced 42.38%	82,463 $3.23 Million
Q1 2021 May 05, 2021	BUY	$33.49 - $37.77 $377,331 - $425,554	11,267 Added 8.54%	143,127 $5.19 Million
Q4 2020 Feb 02, 2021	BUY	$33.47 - $42.56 $48,564 - $61,754	1,451 Added 1.11%	131,860 $4.85 Million
Q3 2020 Oct 30, 2020	BUY	$31.75 - $37.25 $251,269 - $294,796	7,914 Added 6.46%	130,409 $4.79 Million
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $1.11 Million - $1.34 Million	-36,774 Reduced 23.09%	122,495 $4.01 Million
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $16,488 - $23,558	-610 Reduced 0.38%	159,269 $5.2 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $212,334 - $240,972	6,450 Added 4.2%	159,879 $6.26 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $37,915 - $49,165	-1,167 Reduced 0.75%	153,429 $5.51 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $148,474 - $166,702	-4,015 Reduced 2.53%	154,596 $6.7 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $58,987 - $64,807	1,573 Added 1.0%	158,611 $6.74 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $290,910 - $331,669	-7,562 Reduced 4.59%	157,038 $6.85 Million
Q3 2018 Oct 30, 2018	SELL	$34.47 - $41.81 $154,149 - $186,974	-4,472 Reduced 2.65%	164,600 $7.25 Million
Q2 2018 Aug 02, 2018	BUY	$32.98 - $35.16 $422,638 - $450,575	12,815 Added 8.2%	169,072 $6.13 Million
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $198,224 - $229,968	-6,212 Reduced 3.82%	156,257 $5.55 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $500,862 - $531,432	15,059 Added 10.22%	162,469 $5.89 Million
Q3 2017 Nov 06, 2017	SELL	$31.0 - $34.15 $17.6 Million - $19.4 Million	-568,070 Reduced 79.4%	147,410 $5.26 Million
Q2 2017 Aug 11, 2017	BUY	N/A	715,480	715,480 $24 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.

Account